Found 6 matching trials
T-Regulatory Cell Infusion Post Umbilical Cord Blood Transplant in Patients With Advanced Hematologic Cancer PHASE1 RATIONALE: Giving chemotherapy, such as fludarabine and cyclophosphamide, a...
Show More Location
Masonic Cancer Center at University of Minnesota
Learn More & Join Trial
Adoptive TReg Cell for Suppression of aGVHD After UCB HSCT for Heme Malignancies PHASE2 This is a single center pilot study of a non-myeloablative umbilical cord b...
Show More Location
Masonic Cancer Center at University of Minnesota
Learn More & Join Trial
Umbilical Cord Blood T-Regulatory Cell Infusion Followed by Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Leukemia or Other Hematologic Diseases PHASE1 RATIONALE: Giving chemotherapy, such as fludarabine and cyclophosphamide, a...
Show More Location
Masonic Cancer Center at University of Minnesota
Learn More & Join Trial
T-Regulatory Cell and CD3 Depleted Double Umbilical Cord Blood Transplantation in Hematologic Malignancies PHASE1 This is a unique dose-escalation trial that will titrate doses of umbilical...
Show More Location
Masonic Cancer Center, University of Minnesota
Learn More & Join Trial
Treg Cells for AGVHD in Non-myeloablative UCB Transplant PHASE2 This is a Simon's optimal two-stage phase II trial designed to estimate gra...
Show More Location
University of Minnesota Masonic Cancer Center
Learn More & Join Trial
Safety and Efficacy of Umbilical Cord Blood Regulatory T Cells Plus Liraglutide on Autoimmune Diabetes PHASE1 The purpose of this study is to investigate the safety and therapeutic effe...
Show More Location
Institute of Metabolism and Endocrinology, Second Xiangya Hospital, Central South University
Learn More & Join Trial